WallStSmart
ONCT

Oncternal Therapeutics Inc

NASDAQ: ONCT · HEALTHCARE · BIOTECHNOLOGY

$0.53
+0.00% today

Updated 2026-04-30

Market cap
$1.56M
P/E ratio
P/S ratio
0.72x
EPS (TTM)
$-11.69
Dividend yield
52W range
$0 – $0
Volume

Oncternal Therapeutics Inc (ONCT) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20042005200620072008200920102011201220132014201520162017201820192020202120222023
Operating cash flow$-15.67M$-34.82M$-11.46M$-37.63M$-2.92M$-46.00M$-30.53M$-33.09M$-37.11M$-43.97M$-28.76M$-20.04M$-20.78M$-23.46M$-39.35M$-16.75M$-17.50M$-26.59M$-36.70M$-32.16M
Capital expenditures$1.17M$935000.00$578000.00$1.74M$2.90M$600000.00$95000.00$54000.00$142000.00$32000.00$5000.00$4000.00$90000.00$2000.00$0.00$0.00$0.00$0.00$0.00$0.00
Depreciation
Stock-based comp$804000.00$639000.00$1.26M$2.04M$3.71M$5.17M$4.89M$4.23M$2.65M$3.73M$4.43M$2.62M$2.96M$3.15M$2.20M$507000.00$1.56M$5.88M$7.43M$7.50M
Free cash flow$-16.84M$-35.75M$-12.04M$-39.37M$-5.83M$-46.60M$-30.62M$-33.14M$-37.25M$-44.00M$-28.76M$-20.04M$-20.87M$-23.46M$-39.35M$-16.75M$-17.50M$-26.59M$-36.70M$-32.16M
Investing cash flow
Financing cash flow
Dividends paid$455000.00
Share repurchases
Debt repayment
Net change in cash$5.56M$-15.70M$-33.52M$3.35M$-3.82M$-5.15M$6.91M$12.44M$-594000.00$96.69M$-53.62M